Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: a single center experience

N Gopalakrishnan, P Abeesh… - Indian journal of …, 2016 - journals.lww.com
We conducted a prospective study to assess utility of detection of antibodies to
phospholipase A 2 receptor (PLA 2 R) in the serum of patients with membranous …

Antibodies against M-type phospholipase A2 receptor may predict treatment response and outcome in membranous nephropathy

Z Qu, M Zhang, Z Cui, J Wang, M Wang… - American Journal of …, 2018 - karger.com
Background: Anti-phospholipase A2 receptor (PLA2R) antibodies are specific to the
diagnosis of primary membranous nephropathy (pMN). The prevalence of positive …

[HTML][HTML] Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population

MR Ardalan, A Ghafari, F Hamzavi, H Nasri… - Journal of …, 2013 - ncbi.nlm.nih.gov
Background: Idiopathic Membranous Nephropathy (iMN) is the most common cause of
nephrotic syndrome in adults. Approximately one third of patients with iMN progress to end …

Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study

SA Timmermans, JGMC Damoiseaux… - American journal of …, 2014 - academic.oup.com
Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1)
have been demonstrated to be very specific for idiopathic membranous nephropathy (MN) …

Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy

B Svobodova, E Honsova, P Ronco… - Nephrology Dialysis …, 2013 - academic.oup.com
Background Antibodies against M-type phospholipase A2 receptor (PLA2R) are serological
markers of disease activity in patients with idiopathic membranous nephropathy (iMN). To …

Anti-phospholipase A2 receptor antibody in membranous nephropathy

W Qin, LH Beck Jr, C Zeng, Z Chen, S Li… - Journal of the …, 2011 - journals.lww.com
The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic
membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is …

Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy

YG Kim, YW Choi, SY Kim, JY Moon, CG Ihm… - American journal of …, 2015 - karger.com
Background: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful in diagnosing
idiopathic membranous nephropathy (IMN). We investigated the clinical relevance of PLA2R …

Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: Which role in diagnosis and prognosis of this disease?

GS Netti, E Ranieri - Giornale italiano di nefrologia: organo ufficiale …, 2014 - europepmc.org
The discovery of the M-type phospholipase A2 receptor (PLA2R) as a major antigen in
idiopathic membranous nephropathy (iMN) was a breakthrough in understanding the …

[HTML][HTML] Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy

E Hoxha, U Kneißler, G Stege, G Zahner, I Thiele… - Kidney international, 2012 - Elsevier
The M-type phospholipase A2 receptor (PLA 2 R) is the major target antigen in idiopathic
membranous nephropathy with detectable autoantibodies in the serum of up to 70% of …

Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?

JM Hofstra, JF Wetzels - The Netherlands journal of medicine, 2012 - europepmc.org
The identification of circulating autoantibodies against the M-type phospholipase A₂
receptor (anti-PLA₂R) in patients with idiopathic membranous nephropathy (iMN) has been …